Machine Learning may Identify High-Risk Diabetic Cardiomyopathy Phenotype: Study
Researchers have found that using a machine learning-based method, it is possible to identify individuals with diabetes who are most at risk for developing heart failure due to diabetic cardiomyopathy (DbCM). DbCM is a recognized stage of subclinical myocardial abnormalities that precede clinical heart failure (HF), at which echocardiographic and cardiac biomarker abnormalities exist but symptoms of heart failure are absent. The recent study was conducted by Segar and colleagues and was published in the European Journal of Heart Failure.
1,199 participants in diabetes without cardiovascular disease who also did not have causes of cardiomyopathy were included from the cohort of Atherosclerosis Risk in Communities (ARIC). Unsupervised hierarchical approach of clustering stratified individuals based on 25 echocardiographic parameters as well as markers of cardiac biomarkers: neurohormonal markers of stress and markers of myocardial injury. Cluster analysis produced three phenogroups that were differentiated with one labeled as high risk for HF, given that it is associated with an increased rate of HF events at the 5-year follow-up. The data were used to train a DeepNN classifier, which was validated subsequently in two cohorts: the Cardiovascular Health Study (CHS) cohort of n=802 and the EHR cohort from the University of Texas Southwestern Medical Center of n=5071.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.